Bios Life
PrivateLast Round
Seed
Aug 10, 2026
Total Funding Raised
$50M
Momentum
Top 1%
of companies Caplight tracks
Company Overview
Bios Life is a healthtech company that provides an AI-native predictive cancer surveillance and virtual care platform for high-risk individuals and cancer survivors.
Sector
Healthcare & Life Sciences
Verticals
Medical AI, Precision Medicine, Telemedicine, Healthcare Analytics, Patient Engagement
Business Model
B2B
Customer Profile
Services & Consulting, Subscription SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Bios Life Comparables
Compare Bios Life with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| OncoveryCare | 73% | |
| The After Cancer | 69% | |
| Reimagine Care | 68% |
Bios Life Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Aug 10, 2026 | ||||
| Seed | Aug 10, 2026 |
Bios Life Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Redmile Group | Seed |
| Triple Point Ventures | Seed |
| Vsquared Ventures | Seed |
| Kindred Capital | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 10, 2026
$25M raised, led by Redmile Group, Kindred Capital, and Vsquared Ventures.
- Aug 10, 2026
$25M raised, led by Redmile Group, Kindred Capital, and Vsquared Ventures.
Recent news
Latest coverage and updates
- hiresAug 14, 2026
BIOS Life, Inc. hires Thomas Pierrot.
- is_developingAug 13, 2026
Bios Life will develop dynamic "digital twin" cancer risk models on Oct 1st '26.
- partners_withAug 11, 2026
BIOS Life, Inc. partnered with Tempus on Aug 11th '26.
- receives_financingAug 11, 2026
BIOS Life, Inc. received financing of $25M in Seed on Aug 11th '26.
- is_developingAug 10, 2026
Bios Life is developing personalized surveillance strategy to support high-risk individuals and cancer survivors on Aug 10th '26.
Bios Life Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Bios Life's valuation, stock price, and market status.
Is Bios Life a public or private company?
Bios Life is a private company.
What is the current stock price of Bios Life?
Bios Life is a private company with no public stock price. Caplight tracks Bios Life's secondary market activity and provides MarketPrice™ estimates to Caplight users.
How much is Bios Life worth (valuation)?
Valuation information for Bios Life is not publicly available.
Can I buy Bios Life stock?
Bios Life shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Bios Life's last funding round?
Bios Life's most recent funding round was Seed on August 10, 2026.
Who are the main investors in Bios Life?
Key investors in Bios Life include Redmile Group, Vsquared Ventures, Kindred Capital.
Will Bios Life IPO soon?
No public IPO plans have been announced for Bios Life.
How can I track Bios Life secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Bios Life's secondary market activity and sign up for updates.